Impact of minimal residual disease, detected by flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia.
about
Cord-Blood Transplantation in Patients with Minimal Residual DiseaseRole of allogeneic hematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukemia.Prophylaxis and treatment of acute lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation.Low Dose Total Body Irradiation Combined With Recombinant CD19-Ligand × Soluble TRAIL Fusion Protein is Highly Effective Against Radiation-Resistant B-Precursor Acute Lymphoblastic Leukemia in MiceLiposomal Nanoparticles of a Spleen Tyrosine Kinase P-Site Inhibitor Amplify the Potency of Low Dose Total Body Irradiation Against Aggressive B-Precursor Leukemia and Yield Superior Survival Outcomes in MiceMinimal residual disease assessed by multi-parameter flow cytometry is highly prognostic in adult patients with acute lymphoblastic leukaemiaNew drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment?When Less Is Good, Is None Better? The Prognostic and Therapeutic Significance of Peri-Transplant Minimal Residual Disease Assessment in Pediatric Acute Lymphoblastic Leukemia.Detection of non-CLL-like monoclonal B cell lymphocytosis increases dramatically in the very elderly, while detection of CLL-like populations varies by race: findings in a multiethnic population-based cohort of elderly women.Significance of recurrence of minimal residual disease detected by multi-parameter flow cytometry in patients with acute lymphoblastic leukemia in morphological remission.Evaluation of allogeneic transplantation in first or later minimal residual disease - negative remission following adult-inspired therapy for acute lymphoblastic leukemia.Persistent Multiyear Control of Relapsed T-Cell Acute Lymphoblastic Leukemia With Successive Donor Lymphocyte Infusions: A Case ReportLong-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: a landmark analysis.Testing for minimal residual disease in adults with acute lymphoblastic leukemia in Europe: a clinician survey
P2860
Q33911314-5A43E0A4-AFBA-4549-8CAA-6C59651421E0Q34532041-72F84DBF-DF3B-4FEC-AADA-9B1E2082E086Q35100974-72D9AE39-64F6-4F10-9D73-FB599031A18AQ35747708-64D22EA7-397B-4AC2-9350-E345CCC40C6EQ35949248-2121668D-1463-4EB7-9D6C-B9653308A7D9Q36781942-08B587E0-3536-4EC4-91DA-17B9247DB90DQ39307476-2D14DC02-7F8A-4504-B2D1-630D4A75E747Q39420711-4B11967A-B1A5-400B-A617-7E964D0FD3A3Q39549622-85937DE4-DD29-4199-B7D8-9DD0E98659F1Q40396529-A3694A94-E730-4A1C-BDAC-7C8F59F807B9Q41009415-5D3BE6BD-AFD0-4486-97F2-3302A9BE3F31Q41956972-1EBA7388-ACCD-4BA9-92D4-BF15C960E3BAQ49391428-7B331221-2177-4EB2-82D6-FF57E157C881Q59127308-FAE98EE5-328D-4102-98BF-07795ABBCCEE
P2860
Impact of minimal residual disease, detected by flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Impact of minimal residual dis ...... acute lymphoblastic leukemia.
@en
type
label
Impact of minimal residual dis ...... acute lymphoblastic leukemia.
@en
prefLabel
Impact of minimal residual dis ...... acute lymphoblastic leukemia.
@en
P2093
P2860
P356
P1476
Impact of minimal residual dis ...... acute lymphoblastic leukemia.
@en
P2093
Ann E Woolfrey
Brent L Wood
Colleen Delaney
Jerald P Radich
Kristine C Doney
Ted A Gooley
P2860
P304
P356
10.1155/2014/421723
P577
2014-03-23T00:00:00Z